Pavel Mozgunov

Optimal Dose and Safety of Intravenous Favipiravir in Hospitalized Patients With <scp>COVID</scp> ‐19: A Dose‐Escalating, Randomized Controlled Phase Ib Study

Modern Clinical Trials: Seamless Designs and Master Protocols

Design of platform trials with a change in the control treatment arm

Using circulating tumor DNA as a novel biomarker of efficacy for dose-finding designs in oncology

Seamless monotherapy-combination phase I dose-escalation model-based design

How to add baskets to an ongoing basket trial with information borrowing

A randomised-controlled Phase I de-escalation trial of Molnupiravir and Nirmatrelvir/Ritonavir combination for mild-moderate SARS-CoV-2 infection

Clinical and cost-effectiveness of individualised exercises and foot orthoses in the treatment of plantar heel pain: protocol for the TREADON randomised multi-arm multi-stage adaptive trial

Optimal dose and safety of intravenous favipiravir in hospitalised patients with SARS-CoV-2 infection: a Phase Ib, open-label, dose-escalating, randomised controlled study

948P Cancer Research UK first-in-human (FIH) phase I/IIa trial of the prostaglandin E2 (PGE2) receptor 4 (EP4) antagonist HTL0039732 (HTL) as monotherapy and in combination with immunotherapy in patients with advanced solid tumours

A comparison of model-free phase I dose escalation designs for dual-agent combination therapies

A Preplanned Multi‐Stage Platform Trial for Discovering Multiple Superior Treatments With Control of FWER and Power

A multi‐arm multi‐stage platform design that allows preplanned addition of arms while still controlling the family‐wise error

Bayesian model averaging for partial ordering continual reassessment methods

Early phase clinical trials in oncology: Realising the potential of seamless designs

A comparison of Bayesian information borrowing methods in basket trials and a novel proposal of modified exchangeability‐nonexchangeability method

A Bayesian multi‐arm multi‐stage clinical trial design incorporating information about treatment ordering

Determining the minimum duration of treatment in tuberculosis: An order restricted non‐inferiority trial design

Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial

Practical implementation of the partial ordering continual reassessment method in a Phase I combination‐schedule dose‐finding trial

Bayesian sample size determination in basket trials borrowing information between subsets

A Randomised -Controlled Phase 2 trial of Molnupiravir in Unvaccinated and Vaccinated Individuals with Early SARS-CoV-2

Generalization of Cramér-Rao and Bhattacharyya inequalities for the weighted covariance matrix

Shannon's differential entropy asymptotic analysis in a Bayesian problem

&lt;span&gt;Asymptotic behaviour of the weighted Shannon differential entropy in a Bayesian problem&lt;/span&gt;